Your browser doesn't support javascript.
loading
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series.
Smith, Jessica Louise; Menzies, Alexander M; Cohen, Justine V; Mut-Lloret, Margarida; Ozgun, Alpaslan; Spain, Lavinia; Park, John; Quach, Henry T; Pallan, Lalit; McQuade, Jennifer; Feng, Sophie; Sandhu, Shahneen; Atkinson, Victoria; Tsai, Katy; Long, Georgina V; Larkin, James; Eroglu, Zeynep; Johnson, Douglas B; Sullivan, Ryan; Herkes, Geoffrey K; Henderson, Andrew; Carlino, Matteo S.
Afiliação
  • Smith JL; Crown Princess Mary Cancer Centre, Westmead Hospital.
  • Menzies AM; Melanoma Institute Australia, The University of Sydney.
  • Cohen JV; Mater Hospital.
  • Mut-Lloret M; Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Ozgun A; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Spain L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Park J; Moffitt Cancer Center, Tampa, Florida, USA.
  • Quach HT; Royal Marsden NHS Foundation Trust, London, UK.
  • Pallan L; Crown Princess Mary Cancer Centre, Westmead Hospital.
  • McQuade J; Vanderbilt University Cancer Center, Nashville, Tennessee.
  • Feng S; Melanoma Institute Australia, The University of Sydney.
  • Sandhu S; MD Anderson Cancer Center, Houston, Texas, USA.
  • Atkinson V; Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Tsai K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Long GV; Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Larkin J; University of California, San Francisco, San Francisco, California, USA.
  • Eroglu Z; Melanoma Institute Australia, The University of Sydney.
  • Johnson DB; Mater Hospital.
  • Sullivan R; Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Herkes GK; Royal Marsden NHS Foundation Trust, London, UK.
  • Henderson A; Moffitt Cancer Center, Tampa, Florida, USA.
  • Carlino MS; Vanderbilt University Cancer Center, Nashville, Tennessee.
Melanoma Res ; 32(6): 451-459, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36164923
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Melanoma Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Melanoma Res Ano de publicação: 2022 Tipo de documento: Article